BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CRI Worldwide and Lifetree Clinical Research Announce New Company Name—CRI Lifetree


12/7/2011 11:21:52 AM

(Mount Laurel, NJ; December 7, 2011) – CRI Worldwide, a specialized research organization with concentrated expertise in psychiatry, pediatrics, pain and neurology, which recently acquired Lifetree Clinical Research®, has united the two companies under the new name, CRI Lifetree. Accompanying the new name is its strategically focused tagline, “Innovative Solutions. Reliable Results.”

The company integrates CRI’s leadership in psychiatry and expertise in complex studies with Lifetree’s widely recognized clinical trial management and site expertise in Phase I-III pain management and abuse liability studies. Bringing the companies together under one unified name streamlines all branding, communication, and SOPs and processes across the two companies.

“CRI Lifetree is grounded in sound science,” stated Alice Jackson, CRI Lifetree president. “We give our clients the innovation they are looking for—from ‘entrepreneurial’ first-in-human study design to solutions for specialized human abuse liability research.”

“We’re off to a great start; the company is busier than ever,” commented Jeff Kinell, CRI Lifetree CEO. “Since the acquisition, our clients have continued to receive the highest quality service and results, while enriching the early stage clinical research landscape for our sponsors.”

As a clinical research provider with more than 25 years of expertise, CRI Lifetree is a leader in specialized, multi-therapeutic inpatient and outpatient early stage research. The organization offers a broad range of Phase I-IV services and rapid access to specific patient populations to meet the requirements of complex clinical research programs.

About CRI Lifetree

CRI Lifetree is a leader in specialized, multi-therapeutic early stage research providing innovative solutions, high quality and timely results to sponsors. The company has significant expertise in psychiatry, pediatrics pain and neurology, analgesia pain model development, sleep medicine and addiction, and human abuse liability. CRI Lifetree offers a broad range of Phase I-IV services and rapid access to specific patient populations to meet the requirements of complex clinical research programs. Our team works with sponsors in the design and successful execution of drug development programs from first-in-human/MTD, clinical trial management and proof-of-concept, to clinical monitoring and data management/validation/auditing. With sites in New Jersey and Salt Lake City, the company conducts inpatient and outpatient clinical research in special populations and healthy volunteers. For additional information about CRI Lifetree, visit www.criww.com and www.lifetreeresearch.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES